In a report published Tuesday, Goldman Sachs analyst Andrew Rosivach resumed coverage on Health Care REIT HCN with a Neutral rating and $61.00 price target.
In the report, Goldman Sachs noted, “We resume coverage of Health Care REIT, Inc. (HCN) with a Neutral rating and a 12-month price target of $61 (4% total return including dividends). The price target is based on a target 2018E AFFO multiple in line with our sector average, which is warranted given the company's high-quality portfolio, but an estimated lower-than-average earnings growth.”
Health Care REIT closed on Monday at $62.81.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in